Search results
Vertex Pharmaceuticals: Growth Is Still a Better Choice
GuruFocus.com via Yahoo Finance· 4 months agoVertex Pharmaceuticals Inc. (NASDAQ:VRTX) is a leader in the global cystic fibrosis therapeutics...
Takeda maintains annual guidance despite first-quarter profit drop
Reuters via Yahoo Finance· 2 years agoTOKYO (Reuters) -Japan's biggest drugmaker Takeda Pharmaceutical Co reported a sharp drop in...
Japan's Astellas to buy Iveric Bio for $5.9 billion to expand eyesight treatments
Reuters via Yahoo News· 12 months agoTOKYO (Reuters) -Japan's Astellas Pharma said on Monday it agreed to buy U.S. drugmaker Iveric Bio...
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q4 2022 Earnings Call Transcript November 28, 2022...
Takeda, Nintendo among Japanese firms quietly celebrating weak yen
Reuters via Yahoo Finance· 2 years agoJapan's yen is at its weakest in decades and inflicting high costs of imported food and fuel on...
Exelixis' Growth Trajectory Depends on Leading Innovations in Cancer Treatments
GuruFocus.com via Yahoo Finance· 2 months agoExelixis Inc. (NASDAQ:EXEL) is a pharmaceutical company headquartered in Alameda, California that...
U.S. FDA approves Sanofi's bleeding disorder therapy
Reuters via Yahoo News· 1 year ago(Reuters) -The U.S. Food and Drug Administration has approved Sanofi SA's therapy to treat a type of inherited bleeding disorder known as hemophilia A...
Exelixis' (EXEL) Prostate Cancer Study Meets Primary Endpoint
Zacks via Yahoo Finance· 8 months agoExelixis, Inc. EXEL and partner Ipsen announced that the late-stage CONTACT-02 study achieved one of...
Top 20 Most Profitable Pharmaceutical Companies In The World
Insider Monkey via Yahoo Finance· 10 months agoIn this article, we will be covering the top 20 most profitable pharmaceutical companies in the...
Phathom (PHAT) Down on Regulatory Update on Vonoprazan NDA
Zacks via Yahoo Finance· 1 year agoPhathom Pharmaceuticals, Inc. (PHAT) declines as the FDA decides to not take any action on Phathom's...